Author: BusinessWire

New center in Deptford opens to support an urgent patient need for human plasma
DEPTFORD, N.J.–(BUSINESS WIRE)–BioLife Plasma Services, part of the global biopharmaceutical company Takeda, today announced the opening of a new plasma center in Deptfo…

New center in Deptford opens to support an urgent patient need for human plasma
DEPTFORD, N.J.–(BUSINESS WIRE)–BioLife Plasma Services, part of the global biopharmaceutical company Takeda, today announced the opening of a new plasma center in Deptfo…

Research to utilize AgeX’s proprietary BAT cellular product candidate AgeX-BAT1.

Loss of non-shivering thermogenic BAT, also known as brown or good fat, in humans with aging is associated with obesity, type II diabetes, and cardiovascular disease.
…

Research to utilize AgeX’s proprietary BAT cellular product candidate AgeX-BAT1.

Loss of non-shivering thermogenic BAT, also known as brown or good fat, in humans with aging is associated with obesity, type II diabetes, and cardiovascular disease.
…

— Presentation to be webcast on Cortexyme’s website —
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on Alzheimer’s and other degenerative diseases, today announced Ch…

Compact, compliance-ready mass spectrometer with SmartMS technology ideal for routine accurate-mass measurements with minimal setup or training

News Summary:

Facilitates the acquisition of high-quality, accurate-mass data for routine small molecule…

Conference call to take place at 8:30 a.m. ET
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator…

Research to utilize AgeX’s proprietary BAT cellular product candidate AgeX-BAT1.

Loss of non-shivering thermogenic BAT, also known as brown or good fat, in humans with aging is associated with obesity, type II diabetes, and cardiovascular disease.
…

— Presentation to be webcast on Cortexyme’s website —
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on Alzheimer’s and other degenerative diseases, today announced Ch…

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Apnimed, a clinical-stage company focused on advancing pharmacologic treatments for obstructive sleep apnea and related disorders, today announced that the Company’s management team will participate in the Oppenheimer…